The S&P 500 and the Dow Jones Industrial Average are trading near all-time highs. Interestingly, this is despite September’s and October’s reputation for being tough on the markets. Most stock market crashes have occurred during October. With a potential widespread correction looming, investors are taking a chance on penny stocks.
Fears of inflation are running high. Then, there is the increasing tension between the U.S. and China. And to add fuel to the fire, we have the recent turmoil in Afghanistan. Understandably, an investor might be squeamish about adding new stocks to their portfolio at this stage. If you are one of them, then perhaps penny stocks will interest you more.
These companies are dirt cheap but have interesting business models. Remember, there are several hidden gems just waiting to be uncovered in this space.
Take Ford (NYSE:F) as an example. During the 2008 financial crisis, shares of the iconic car company hit an all-time low of $2 per share. Now they are changing hands for just under $13 a pop.
Best Penny Stocks To Watch For 2023: Intellipharmaceutics International Inc.(IPCI)
Intellipharmaceutics International Inc. engages in the research, development, and manufacture of novel or generic controlled and targeted release oral solid dosage drugs. The company?s patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of various existing and new pharmaceuticals. It has a pipeline of products in various stages of development in therapeutic areas, including neurology, cardiovascular, and gastrointestinal tract, pain, and infection. The company?s lead generic product under development includes generic Focalin XR (dexmethylphenidate hydrochloride), an extended-release capsule for the treatment of attention deficit hyperactivity disorder. Intellipharmaceutics has a license and commercialization agreement with Par Pharmaceutical, Inc. for the development and commercialization of generic Focalin XR. The company also has five generic products filed with the FDA, including a gene ric of Effexor XR (venlafaxine hydrochloride), an extended-release capsule for depression; Protonix (pantoprazole sodium), a delayed-release tablet for conditions associated with gastroesophageal disease; Glucophage XR (metformin hydrochloride), an extended-release tablet for managing type 2 diabetes; Seroquel XR (quetiapine fumarate), an extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorder; and Lamictal XR (lamotrigine), an extended-release tablet for the treatment of anti-convulsant for epilepsy. Its lead non-generic product under development is Rexista (oxycodone), an abuse- and alcohol-deterrent controlled-release oral oxycodone hydrochloride formulation for the relief of pain. The company also has a under late stage development product, such as Coreg CR (carvedilol phosphate), an extended-release capsule for hypertension and heart conditions. IntelliPharmaCeutics International Inc. was founded in 1998 and is based i n Toronto, Canada.
Advisors’ Opinion:
- [By Max Byerly]
IntelliPharmaCeutics Intl Inc (NASDAQ:IPCI) (TSE:I)’s share price traded down 17.1% on Monday . The company traded as low as $0.32 and last traded at $0.34. 531,615 shares changed hands during trading, an increase of 90% from the average session volume of 280,459 shares. The stock had previously closed at $0.41.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on IntelliPharmaCeutics Intl (IPCI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
IntelliPharmaCeutics Intl (NASDAQ:IPCI) (TSE:I)’s stock had its “hold” rating restated by equities researchers at Maxim Group in a research report issued on Friday. They presently have a $8.00 price target on the stock.
Best Penny Stocks To Watch For 2023: Pound/Rand(PX)
Praxair, Inc. engages in the production, distribution, and sale atmospheric and process gases, as well as surface coatings in North America, Europe, South America, and Asia. The company offers atmospheric gases, such as oxygen, nitrogen, argon, and rare gases; and process gases comprising carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene. It also designs, engineers, and builds equipment that produces industrial gases; and manufactures precious metal and ceramic sputtering targets used primarily in the production of semiconductors. In addition, the company supplies surface coatings consisting of wear-resistant and high-temperature corrosion-resistant metallic and ceramic coatings and powders to the aircraft, energy, printing, textile, plastics, primary metals, petrochemical, and other industries. Further, it provides electric arc, plasma, and oxygen fuel spray equipment, as well as arc and flame wire equipment used for the application of wea r-resistant coatings; and distributes welding equipment purchased from independent manufacturers. The company sells its products primarily through independent distributors. It serves various industries, such as healthcare, petroleum refining, computer-chip manufacturing, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, and water treatment industries. The company was founded in 1907 and is headquartered in Danbury, Connecticut.
Advisors’ Opinion:
- [By Shane Hupp]
Praxair (NYSE:PX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Praxair is expected to gain from strong backlog, new order wins and recovery in the energy and industrial end markets. Notably, Praxair’s pending merger with Linde has received conditional EU antitrust approval, antitrust clearance in China and India. Praxair and Linde also agreed to sell additional assets to a consortium of Messer Group GmbH and CVC Capital Partners in order to obtain the U.S. antitrust approval. The companies continue to work diligently to close the merger in second-half 2018. The stock has also outperformed its industry over the past year. However, its results will be hurt by weaker volumes and political uncertainties prevalent in Brazil and currency headwinds. Further, inflation and rising freight and logistics costs will hurt margins. Praxair’s stretched valuation is also a concern.”
- [By Max Byerly]
Praxair, Inc. (NYSE:PX)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $169.00 and last traded at $168.83, with a volume of 72450 shares changing hands. The stock had previously closed at $160.73.
- [By Max Byerly]
Get a free copy of the Zacks research report on Praxair (PX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Best Penny Stocks To Watch For 2023: Kingstone Companies, Inc(KINS)
Kingstone Companies, Inc., through its subsidiary, Kingstone Insurance Company, underwrites property and casualty insurance products to small businesses and individuals in New York. The company provides personal lines insurance products, such as homeowners, dwelling fire, 3-4 family dwelling package, condominium, renters, equipment breakdown, service line endorsements, and personal umbrella policies; and commercial liability policies comprising small business retail, service, and office risks without residential exposure to business owners. It also offers for-hire vehicle physical damage only policies for livery and car service vehicles and taxicabs; and canine legal liability policies, as well as reinsurance products. In addition, the company, through its subsidiary, Payments, Inc., places contracts with a third party licensed premium finance company. Kingstone Companies, Inc. sells its products through independent retail and wholesale agents and brokers. The company was formerly known as DCAP Group, Inc. and changed its name to Kingstone Companies, Inc. in July 2009. Kingstone Companies, Inc. was founded in 1886 and is based in Kingston, New York.
